Form 4 for ACRS Aclaris Therapeutics, Inc.
Accepted 2023-06-22 00:00:00 ET · period of report 2023-06-20 · accession 0001209191-23-039080 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-22 | 2023-06-20 | ACRS | Molineaux Christopher P. | Dir | M - OptEx | $1.41 | +16.5K | 48.5K | +52% | +$23.3K |
| D | 2023-06-22 | 2023-06-20 | ACRS | Molineaux Christopher P. | Dir | M - OptEx | $0.00 | -16.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-20 | M | A | 16,500 | $1.41 | 48,503 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2023-06-20 | M | D | 16,500 | $0.00 | 0 | D | $1.41 · — to 2030-06-03 | 16,500 Common Stock | (F1) The shares underlying this option vested in twelve equal monthly installments commencing July 4, 2020, subject to the reporting person's continued service with the Issuer as of the applicable vesting date. |